JPS60224616A - 経鼻投与用組成物 - Google Patents

経鼻投与用組成物

Info

Publication number
JPS60224616A
JPS60224616A JP59081034A JP8103484A JPS60224616A JP S60224616 A JPS60224616 A JP S60224616A JP 59081034 A JP59081034 A JP 59081034A JP 8103484 A JP8103484 A JP 8103484A JP S60224616 A JPS60224616 A JP S60224616A
Authority
JP
Japan
Prior art keywords
water
nasal administration
absorbing
composition
powdered composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59081034A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6242888B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Yoshiki Suzuki
嘉樹 鈴木
Kunio Sekine
関根　邦男
Tsuneji Nagai
永井　恒司
Naoki Nanbu
南部　直樹
Yuji Nishimoto
西本　裕二
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP59081034A priority Critical patent/JPS60224616A/ja
Publication of JPS60224616A publication Critical patent/JPS60224616A/ja
Publication of JPS6242888B2 publication Critical patent/JPS6242888B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP59081034A 1984-04-24 1984-04-24 経鼻投与用組成物 Granted JPS60224616A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59081034A JPS60224616A (ja) 1984-04-24 1984-04-24 経鼻投与用組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59081034A JPS60224616A (ja) 1984-04-24 1984-04-24 経鼻投与用組成物

Publications (2)

Publication Number Publication Date
JPS60224616A true JPS60224616A (ja) 1985-11-09
JPS6242888B2 JPS6242888B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-09-10

Family

ID=13735169

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59081034A Granted JPS60224616A (ja) 1984-04-24 1984-04-24 経鼻投与用組成物

Country Status (1)

Country Link
JP (1) JPS60224616A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62190119A (ja) * 1986-01-24 1987-08-20 アクゾ・エヌ・ヴエ− 高粘度ヒドロゲル又は懸濁液を得るための製剤
JPS632932A (ja) * 1986-06-23 1988-01-07 Teijin Ltd 経鼻投与用粉末状組成物
JPS63115822A (ja) * 1986-11-04 1988-05-20 Teijin Ltd 生理活性ポリペプチド類の経鼻投与用粉末状組成物
JPS63115820A (ja) * 1986-10-31 1988-05-20 Teijin Ltd アスコルビン酸類を含有する経鼻投与用粉末状組成物
JPH01500116A (ja) * 1986-04-18 1989-01-19 ノボ　ノルデイスク　アクツイエセルスカプ インシユリン製剤
AT396331B (de) * 1986-08-18 1993-08-25 Sandoz Ag Verfahren zur herstellung einer octreotid enthaltenden pharmazeutischen zusammensetzung
FR2705895A1 (fr) * 1993-06-04 1994-12-09 Merck Patent Gmbh Comprimés médicamenteux exempts d'agent lubrifiant.
US5399341A (en) * 1990-06-21 1995-03-21 Huland; Edith Use of cytokin-containing aerosols and the cytokin-containing aerosols
WO1997031626A1 (fr) * 1996-02-27 1997-09-04 Teijin Limited Composition pulverulente destinee a une adminstration nasale
US5780012A (en) * 1990-06-21 1998-07-14 Huland; Edith Method for reducing lung afflictions by inhalation of cytokine solutions
WO2003004048A1 (en) * 2001-07-05 2003-01-16 Translational Research Ltd. Compositions for nasal administration of insulin
US6589559B1 (en) 1999-02-22 2003-07-08 Dott Research Laboratory Nasally administrable compositions
KR100388932B1 (ko) * 1994-10-17 2003-09-19 악조 노벨 엔.브이. 물을결합시킬수있는부형제를포함하는고형약학조성물
US7235247B2 (en) 1998-04-21 2007-06-26 Teijin Pharma Limited Pharmaceutical composition for application to mucosa
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
US8337817B2 (en) 2006-12-26 2012-12-25 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
US8673360B2 (en) 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
US8802622B2 (en) 2010-03-19 2014-08-12 Daiichi Sankyo Company, Limited Composition for nasal administration and method for preparing same
US8827946B2 (en) 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
USRE45404E1 (en) 2003-03-27 2015-03-03 Shin Nippon Biomedical Laboratories, Ltd. Powder medicine applicator for nasal cavity
US9101539B2 (en) 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2518102C (en) 2003-03-04 2009-05-12 Tanabe Seiyaku Co., Ltd. Powdery preparation for nasal administration
CA3083757A1 (en) * 2017-11-27 2019-05-31 Aska Pharmaceutical Co., Ltd. Powder preparation for nasal administration

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62190119A (ja) * 1986-01-24 1987-08-20 アクゾ・エヌ・ヴエ− 高粘度ヒドロゲル又は懸濁液を得るための製剤
JPH01500116A (ja) * 1986-04-18 1989-01-19 ノボ　ノルデイスク　アクツイエセルスカプ インシユリン製剤
JPS632932A (ja) * 1986-06-23 1988-01-07 Teijin Ltd 経鼻投与用粉末状組成物
AT396331B (de) * 1986-08-18 1993-08-25 Sandoz Ag Verfahren zur herstellung einer octreotid enthaltenden pharmazeutischen zusammensetzung
JPS63115820A (ja) * 1986-10-31 1988-05-20 Teijin Ltd アスコルビン酸類を含有する経鼻投与用粉末状組成物
JPS63115822A (ja) * 1986-11-04 1988-05-20 Teijin Ltd 生理活性ポリペプチド類の経鼻投与用粉末状組成物
US5399341A (en) * 1990-06-21 1995-03-21 Huland; Edith Use of cytokin-containing aerosols and the cytokin-containing aerosols
US5780012A (en) * 1990-06-21 1998-07-14 Huland; Edith Method for reducing lung afflictions by inhalation of cytokine solutions
FR2705895A1 (fr) * 1993-06-04 1994-12-09 Merck Patent Gmbh Comprimés médicamenteux exempts d'agent lubrifiant.
KR100388932B1 (ko) * 1994-10-17 2003-09-19 악조 노벨 엔.브이. 물을결합시킬수있는부형제를포함하는고형약학조성물
WO1997031626A1 (fr) * 1996-02-27 1997-09-04 Teijin Limited Composition pulverulente destinee a une adminstration nasale
EP0943326A4 (en) * 1996-02-27 2000-12-20 Teijin Ltd PULVERULENT COMPOSITION FOR NASAL ADMINSTRATION
US8206748B2 (en) 1996-02-27 2012-06-26 Teijin Limited Powdery composition for nasal administration
AU722319B2 (en) * 1996-02-27 2000-07-27 Teijin Limited Powdery composition for nasal administration
US7731990B2 (en) 1996-02-27 2010-06-08 Teijin Limited Powdery composition for nasal administration
US7235247B2 (en) 1998-04-21 2007-06-26 Teijin Pharma Limited Pharmaceutical composition for application to mucosa
US6589559B1 (en) 1999-02-22 2003-07-08 Dott Research Laboratory Nasally administrable compositions
WO2004078214A1 (ja) * 1999-02-22 2004-09-16 Akira Yanagawa 経鼻吸収用組成物
US6906027B2 (en) 2001-07-05 2005-06-14 Translational Research Ltd. Composition for nasal administration of insulin
CN100341567C (zh) * 2001-07-05 2007-10-10 产业化研究株式会社 胰岛素的经鼻给药用组合物
WO2003004048A1 (en) * 2001-07-05 2003-01-16 Translational Research Ltd. Compositions for nasal administration of insulin
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
US8435554B2 (en) 2003-02-21 2013-05-07 Shin Nippon Biomedical Laboratories, Ltd. Compositons for nasal administration of pharmaceuticals
US9138410B2 (en) 2003-02-21 2015-09-22 Shin Nippon Biomedical Laboratories, Ltd. Compositions for nasal administration of pharmaceuticals
USRE45404E1 (en) 2003-03-27 2015-03-03 Shin Nippon Biomedical Laboratories, Ltd. Powder medicine applicator for nasal cavity
US8673360B2 (en) 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
US8337817B2 (en) 2006-12-26 2012-12-25 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
US10195139B2 (en) 2006-12-26 2019-02-05 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
US9101539B2 (en) 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
US8827946B2 (en) 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US8802622B2 (en) 2010-03-19 2014-08-12 Daiichi Sankyo Company, Limited Composition for nasal administration and method for preparing same
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
US12102754B2 (en) 2017-09-26 2024-10-01 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Also Published As

Publication number Publication date
JPS6242888B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-09-10

Similar Documents

Publication Publication Date Title
JPS60224616A (ja) 経鼻投与用組成物
EP0122036B1 (en) Powdery pharmaceutical composition for nasal administration
CA1333258C (en) Transmucosal formulations
JPS632932A (ja) 経鼻投与用粉末状組成物
CA2247191C (en) Powdery composition for nasal administration
US4985242A (en) Intranasally applicable powdery pharmaceutical composition
JP2974409B2 (ja) 微粒子薬物組成物
US5690954A (en) Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US6835389B1 (en) Powder Composition for nasal administration
TW553746B (en) Powdery nasal composition
JP2851627B2 (ja) 粉末形態ポリプペチド類の経鼻投与
CA2375914A1 (en) Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
NO178564B (no) Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner
JPH10501519A (ja) インシュリンを肺に送給できる方法および組成物
JPH07165613A (ja) 経鼻吸収薬物用キャリヤおよび生理活性ペプチド組成物
JP3197221B2 (ja) 吸収性が改善された粉末状経鼻投与組成物
JP2505430B2 (ja) 塩基性アミノ酸を含有する経鼻投与用粉末状組成物
GB2193891A (en) Nasal pharmaceutical compositions containing octreotide
JP2802488B2 (ja) 経鼻吸収用生理活性ペプチド組成物
CA2291765A1 (en) Pharmaceutical compositions of peptides having low solubility in physiological medium
JP3197223B2 (ja) 即効性と持続性を兼ね備えた粉末状経鼻投与用組成物
JPH0480008B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0688898B2 (ja) アスコルビン酸類を含有する経鼻投与用粉末状組成物
JP3197222B2 (ja) 粉末状経鼻投与組成物
JPH05170663A (ja) カルシトニン点鼻用医薬組成物

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term